+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prophylactic treatment of venous thromboembolic disease in palliative care. A survey about four different clinical cases



Prophylactic treatment of venous thromboembolic disease in palliative care. A survey about four different clinical cases



Presse Medicale 38(9): 1235-1239



There are no specific studies evaluating the benefit/risk of antithrombotic prophylactic treatment in patients hospitalised in a palliative care unit. So, the aim of this study was to evaluate the clinicians attitudes about antithrombotic prophylaxis for patients in palliative care units and the elements which determined their decisions. The clinical data of 4 terminally ill patients were extracted from database of a Palliative Care Unit in France. These 4 patients were selected as they represented several different situations according to the presence or not of major thrombotic risk factors, bleeding risk factors, and request of compassionate care. Through an open questionnaire, fourteen clinicians usually in charge of palliative care patients were individually interviewed about antithrombotic prophylactic therapy for each case of patients. except in the case of a patient with major thrombotic risk factors, no bleeding risk factor and wishing to receive active care, both the attitudes of clinicians to initiate or continue a prophylactic therapy and the elements which lead to their decisions were heterogeneous at least. the absence of recommendations based on validated clinical trials evaluating the efficacy and safety of thromboembolism prophylactic treatment in palliative care patients lead to uncertain decisions for clinicians. Added to an objective evaluation of thrombotic and hemorrhagic risks factors, the wish of patient to receive or not active care is probably the most important element to consider.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055231946

Download citation: RISBibTeXText

PMID: 19375271

DOI: 10.1016/j.lpm.2008.11.021


Related references

Have palliative care teams' attitudes toward venous thromboembolism changed? A survey of thromboprophylaxis practice across British specialist palliative care units in the years 2000 and 2005. Journal of Pain and Symptom Management 32(1): 38-43, 2006

Prophylactic anticoagulation for venous thromboembolic disease in geriatric patients. Journal of the American Geriatrics Society 51(10): 1472-1478, 2003

Clinical scores for the venous thromboembolic disease: an aid for the diagnosis and the treatment?. Revue Medicale Suisse 11(464): 570-573, 2015

Clinical guideline for diagnosis and treatment of the thromboembolic venous disease. Revista Medica del Instituto Mexicano del Seguro Social 49(4): 437-449, 2011

A randomised, multicentre clinical trial of specialised palliative care plus standard treatment versus standard treatment alone for cancer patients with palliative care needs: the Danish palliative care trial (DanPaCT) protocol. Bmc Palliative Care 12(1): 37-37, 2013

Depression in palliative care patients: a survey of assessment and treatment practices of Australian and New Zealand palliative care specialists. Australian Health Review 38(1): 44-50, 2014

Survey of clinical practice in the prevention, diagnosis and treatment of thromboembolic disease. British Journal of Haematology 86(SUPPL 1): 22, 1994

Clinical and health costs impact of progress in diagnosis and treatment in venous thromboembolic disease: evolution in 15 years. Annals of Vascular Surgery 27(8): 1162-1168, 2014

Conformance of clinical practice to established recommendations for the diagnosis and treatment of venous thromboembolic disease: Robin revisited. American Journal of Medical Quality 9(4): 153-157, 1994

Resource utilization and costs of care for inpatient treatment of venous thromboembolic disease in a randomized trial of enoxaparin versus unfractionated heparin. Blood 94(10 SUPPL 1 PART 1): 184a, Nov 15, 1999

Greenfield vena caval filter for management of selected cases of venous thromboembolic disease following hip surgery. A report of five cases. Clinical Orthopaedics and Related Research: 201-206, 1986

Clinical outcomes and patient satisfaction of a pharmacist-managed, emergency department-based outpatient treatment program for venous thromboembolic disease. Cjem 10(1): 10-17, 2008

Abrupt versus gradual withdrawal of vitamin K antagonist treatment in patients with venous thromboembolic disease: assessment of hypercoagulability and clinical outcome. Clinical Laboratory 46(11-12): 575-581, 2000

Venous thromboembolic diseases in the aged. Survey of patients living in long-term care facilities. Presse Medicale 28(6): 282-282, 1999

An aetiological survey of venous thromboembolic disease. What examinations for which patients? 104 observations. Presse Medicale 32(28): 1310-1316, 2003